To date, there has been limited knowledge regarding the clinical features of pediatric Sjögren’s syndrome and its impact on quality of life. Because it is rare, it is often diagnosed late, and there is a lack of validated pediatric endpoints. British researchers have now investigated clinical phenotypes, disease activity, symptom burden, and treatment experience.
Autoren
- Jens Dehn
Publikation
- InFo RHEUMATOLOGIE
Related Topics
You May Also Like
- Sjögren's Syndrome in Early Childhood
Children often develop lymphomas
- Multidrug-Resistant Pathogens in Wound Care
An Enemy in the Microbiome?
- Rare Genodermatoses: From Diagnosis to Treatment
Darier’s Disease, also known as Follicular Keratosis – Update 2026
- Psychedelic-assisted therapy
Current status of PAT
- Osgood-Schlatter Disease
Clinical Presentation, Diagnosis, and Treatment
- Cardiovascular Risk in Rheumatoid Arthritis
What is the most dangerous thing for RA?
- Antisense oligonucleotide for severe hypertriglyceridemia
Reduced Incidence of Acute Pancreatitis
- Hereditary Transthyretin Amyloidosis with Polyneuropathy